A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal Cancer

Clinical trial NCT06746298 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06746298
Sponsor: Shanghai Minimally Invasive Surgery Center
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Rectal Cancer Neoadjuvant Therapy

Start date: 2025-01-01
Primary completion: 2026-05-31
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.